Sanofi (0A2V) Stock Statistics & Valuation Metrics

Sanofi has a market cap or net worth of $114.40B. The enterprise value is $122.96B.

Market Cap

$114.40B

Enterprise Value

$122.96B

Sanofi has 2,415,546,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,415,546,900

Owned by Insiders

―

Owned by Institutions

2.91%

Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.70%.

Return on Equity (ROE)

0.11

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

7.70%

Return on Capital Employed (ROCE)

0.10

Revenue Per Employee

610.72K

Profits Per Employee

102.14K

Employee Count

76,493

Asset Turnover

0.37

Inventory Turnover

1.28

The current PE Ratio of Sanofi is 24.82. Sanofi’s PEG ratio is -0.46.

PE Ratio

24.82

PS Ratio

2.04

PB Ratio

1.43

Price to FCF

6.30

Price to Operating Cash Flow

6.02

PEG Ratio

-0.46

In the last 12 months, Sanofi had revenue of 46.72B and earned 7.81B in profits. Earnings per share was 3.20.

Revenue

46.72B

Gross Profit

33.67B

Operating Income

9.60B

Pretax Income

6.02B

Net Income

7.81B

EBITDA

12.48B

Earnings Per Share (EPS)

3.20

In the last 12 months, operating cash flow was 14.29B and capital expenditures -2.52B, giving a free cash flow of 11.77B billion.

Operating Cash Flow

14.29B

Free Cash Flow

11.77B

Free Cash Flow per Share

6.87

Sanofi pays an annual dividend of ―, resulting in a dividend yield of 5.30%

Dividend Per Share

―

Dividend Yield

5.30%

Payout Ratio

N/A

Free Cash Flow Yield

15.88%

Earnings Yield

4.02%

Beta

0.81

52-Week Price Change

-7.11%

50-Day Moving Average

42.34

200-Day Moving Average

43.76

Relative Strength Index (RSI)

76.25

Average Volume (3m)

35.77K

Sanofi upcoming earnings date is Jan 28, 2027, Before Open (Not Confirmed).

Last Earnings Date

Oct 30, 2026

Next Earnings Date

Jan 28, 2027

Ex-Dividend Date

―

Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 28.48%

Current Ratio

1.09

Quick Ratio

0.73

Debt to Market Cap

0.18

Net Debt to EBITDA

1.02

Interest Coverage Ratio

15.33

In the past 12 months, Sanofi has paid 1.04B in taxes.

Income Tax

1.04B

Effective Tax Rate

0.17

Sanofi EV to EBITDA ratio is 7.97, with an EV/FCF ratio of 7.14.

EV to Sales

2.31

EV to EBITDA

7.97

EV to Free Cash Flow

7.14

EV to Operating Cash Flow

6.81

Sanofi has $6.35B in cash and marketable securities with $23.58B in debt, giving a net cash position of -$17.23B billion.

Cash & Marketable Securities

$6.35B

Total Debt

$23.58B

Net Cash

-$17.23B

Net Cash Per Share

-$7.13

Tangible Book Value Per Share

$0.52

Gross margin is 73.44%, with operating margin of 21.55%, and net profit margin of 8.19%.

Gross Margin

73.44%

Operating Margin

21.55%

Pretax Margin

11.59%

Net Profit Margin

8.19%

EBITDA Margin

28.96%

EBIT Margin

13.44%

The average price target for Sanofi is $59.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$59.50

Price Target Upside

24.07% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

23.68%

EPS Growth Forecast

-30.90%

Smart Score

6

AI Score

―